GlassScriptPhysician profile
John Newton Clore
NPI 1023108669
$1,558.95
in general payments reported to CMS, 2019-2025
20 companies · $538 in 2025
The $538 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $19.90 · 2021: $62.80 · 2022: $371 · 2023: $179 · 2024: $210 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $288.41 | 2025 | |
| Abbott Laboratories | $233.41 | 2021-2022 | |
| Cequr Corporation | $176.34 | 2023-2025 | Cequr Simplicity |
| Dexcom, INC. | $151.38 | 2019-2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $143.68 | 2019-2023 | Omnipod |
| Lilly USA, LLC | $117.00 | 2024 | Zepbound |
| Novo Nordisk INC | $89.88 | 2019-2023 | Wegovy |
| Medtronic, INC. | $48.55 | 2022-2023 | Minimed 780g |
| Beta Bionics, INC. | $44.41 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ascensia Diabetes Care US INC. | $41.14 | 2020-2025 | |
| Valeritas, INC. | $35.36 | 2019 | |
| Sequel Med Tech, LLC | $28.89 | 2025 | Twiist |
| Becton, Dickinson and Company | $28.77 | 2022 | |
| Tandem Diabetes Care, INC. | $27.54 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amneal Pharmaceuticals LLC | $22.74 | 2023 | Unithroid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.41 | 2019 | |
| Echosens North America, INC. | $16.37 | 2019 | |
| Medtronic Minimed, INC. | $15.72 | 2019 | |
| Amarin Pharma, INC. | $15.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Clore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.